0 CHECKOUT

Synta Pharmaceuticals Corp. (SNTA) - Financial and Strategic SWOT Analysis Review

  • ID: 1322625
  • June 2015
  • 58 pages
  • GlobalData

FEATURED COMPANIES

  • Abbott Laboratories
  • Amgen Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • MORE

Synta Pharmaceuticals Corp. (SNTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Amgen Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • MORE

List of Tables
List of Figures
Section 1 - About the Company
Synta Pharmaceuticals Corp. - Key Facts
Synta Pharmaceuticals Corp. - Key Employees
Synta Pharmaceuticals Corp. - Key Employee Biographies
Synta Pharmaceuticals Corp. - Major Products and Services
Synta Pharmaceuticals Corp. - Pharmaceutical Pipeline Products Data
Synta Pharmaceuticals Corp., Pipeline Products by Therapy Area
Synta Pharmaceuticals Corp., Pipeline Products by Development Phase
Synta Pharmaceuticals Corp. - History
Synta Pharmaceuticals Corp. - Company Statement
Synta Pharmaceuticals Corp. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Synta Pharmaceuticals Corp. - Business Description
Synta Pharmaceuticals Corp. - Corporate Strategy
Synta Pharmaceuticals Corp. - SWOT Analysis
SWOT Analysis - Overview
Synta Pharmaceuticals Corp. - Strengths
Strength - Intellectual Property Portfolio
Strength - Focused Research and Development Activities
Strength - Proprietary Technology Platform
Synta Pharmaceuticals Corp. - Weaknesses
Weakness - History of losses
Weakness - Reliance on Third Parties
Weakness - Competitive Positioning
Synta Pharmaceuticals Corp. - Opportunities
Opportunity - Strong Pipeline of Drug Candidates
Opportunity - Changing Demographics
Opportunity - Market Potential: Cancer
Synta Pharmaceuticals Corp. - Threats
Threat - Intense Competition
Threat - Increased Drug Scrutiny
Threat - Uncertain R&D Outcomes
Synta Pharmaceuticals Corp. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Synta Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Synta Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Synta Pharmaceuticals Corp., Recent Deals Summary
Section 5 – Company’s Recent Developments
May 07, 2015: Synta Reports First Quarter 2015 Financial Results
Apr 27, 2015: Synta Announces Chen Schor Named President, Chief Executive Officer and Director
Mar 12, 2015: Synta Reports Fourth Quarter and Year-End 2014 Financial Results
Feb 05, 2015: Synta Outlines New Corporate Strategy
Dec 04, 2014: Synta Strengthens Management Team with Two Executive Appointments
Nov 06, 2014: Synta Reports Third Quarter Financial Results and Provides Corporate Update
Aug 06, 2014: Synta Names Anne Whitaker Chief Executive Officer
Aug 06, 2014: Synta Reports Second Quarter Financial Results and Provides Corporate Update
May 08, 2014: Synta Reports First Quarter 2014 Financial Results and Provides Corporate Update
Mar 11, 2014: Synta Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Synta Pharmaceuticals Corp., Key Facts
Synta Pharmaceuticals Corp., Key Employees
Synta Pharmaceuticals Corp., Key Employee Biographies
Synta Pharmaceuticals Corp., Major Products and Services
Synta Pharmaceuticals Corp., Number of Pipeline Products by Therapy Area
Synta Pharmaceuticals Corp., Number of Pipeline Products by Development Stage
Synta Pharmaceuticals Corp., Pipeline Products By Therapy Area and Development Phase
Synta Pharmaceuticals Corp., History
Synta Pharmaceuticals Corp., Other Locations
Synta Pharmaceuticals Corp., Subsidiaries
Synta Pharmaceuticals Corp., Key Competitors
Synta Pharmaceuticals Corp., Ratios based on current share price
Synta Pharmaceuticals Corp., Annual Ratios
Synta Pharmaceuticals Corp., Interim Ratios
Synta Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Synta Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Synta Pharmaceuticals Corp., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Synta Pharmaceuticals Corp., Pipeline Products by Therapy Area
Synta Pharmaceuticals Corp., Pipeline Products by Development Phase
Synta Pharmaceuticals Corp., Performance Chart (2010 - 2014)
Synta Pharmaceuticals Corp., Ratio Charts
Synta Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Synta Pharmaceuticals Corp., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015

Note: Product cover images may vary from those shown

Infinity Pharmaceuticals, Inc.
Abbott Laboratories
Pfizer Inc.
Amgen Inc.
Johnson & Johnson
Onyx Pharmaceuticals, Inc.
Advanced Life Sciences holdings, Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Alexion Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Endo International Plc.
  • Essilor International S.A.